Literature DB >> 8817185

Injecting drug use as risk factor for visceral leishmaniasis in AIDS patients.

C Amela1, D López-Gay, J C Alberdi, J Castilla.   

Abstract

In Madrid Region 6652 AIDS cases were diagnosed between 1982 and 1993. Visceral leishmaniasis (VL) was present in 166 (2.49%). VL frequency among injecting drug users proved higher than that for the other transmission categories (relative risk 2.57; 95% confidence interval 1.64-4.01). This could point to an alternative Leishmania transmission route via needle sharing.

Entities:  

Mesh:

Year:  1996        PMID: 8817185     DOI: 10.1007/bf00144435

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  6 in total

1.  Prevalence of Leishmania infection among AIDS patients.

Authors:  J Alvar; B Gutiérrez-Solar; R Molina; R López-Velez; A Garcia-Camacho; P Martinez; F Laguna; E Cercenado; A Galmes
Journal:  Lancet       Date:  1992-06-06       Impact factor: 79.321

2.  Visceral leishmaniasis: another HIV-associated opportunistic infection? Report of eight cases and review of the literature.

Authors:  J Altés; A Salas; M Riera; M Udina; A Galmés; J Balanzat; A Ballesteros; J Buades; F Salvá; C Villalonga
Journal:  AIDS       Date:  1991-02       Impact factor: 4.177

3.  Could infected drug-users be potential Leishmania infantum reservoirs?

Authors:  J Alvar; M Jiménez
Journal:  AIDS       Date:  1994-06       Impact factor: 4.177

4.  Indirect xenodiagnosis of visceral leishmaniasis in 10 HIV-infected patients using colonized Phlebotomus perniciosus.

Authors:  R Molina; C Cañavate; E Cercenado; F Laguna; R López-Vélez; J Alvar
Journal:  AIDS       Date:  1994-02       Impact factor: 4.177

5.  Leishmaniasis and AIDS co-infection: the Spanish example.

Authors:  J Alvar
Journal:  Parasitol Today       Date:  1994-04

6.  Visceral leishmaniasis in HIV-infected patients in the south of France.

Authors:  J Dereure; J Reynes; F Pratlong; I Lamaury; J A Rioux; F Janbon; J P Dedet
Journal:  Bull World Health Organ       Date:  1995       Impact factor: 9.408

  6 in total
  6 in total

1.  Mediterranean leishmaniasis in HIV-infected patients: epidemiological, clinical, and diagnostic features of 22 cases.

Authors:  C Agostoni; N Dorigoni; A Malfitano; L Caggese; G Marchetti; S Corona; S Gatti; M Scaglia
Journal:  Infection       Date:  1998 Mar-Apr       Impact factor: 3.553

2.  Incidence of and risk factors for symptomatic visceral leishmaniasis among human immunodeficiency virus type 1-infected patients from Spain in the era of highly active antiretroviral therapy.

Authors:  Rafael de La Rosa; Juan A Pineda; Juan Delgado; Juan Macías; Francisco Morillas; José A Mira; Armando Sánchez-Quijano; Manuel Leal; Eduardo Lissen
Journal:  J Clin Microbiol       Date:  2002-03       Impact factor: 5.948

3.  Prevalence of and factors associated with visceral leishmaniasis in human immunodeficiency virus type 1-infected patients in southern Spain.

Authors:  J A Pineda; J A Gallardo; J Macías; J Delgado; C Regordán; F Morillas; F Relimpio; J Martín-Sánchez; A Sánchez-Quijano; M Leal; E Lissen
Journal:  J Clin Microbiol       Date:  1998-09       Impact factor: 5.948

4.  Prevalence of Human Immunodeficiency Virus and associated factors among Visceral Leishmaniasis infected patients in Northwest Ethiopia: a facility based cross-sectional study.

Authors:  Mekuriaw Alemayehu; Mamo Wubshet; Nebiyu Mesfin; Abebaw Gebayehu
Journal:  BMC Infect Dis       Date:  2017-02-17       Impact factor: 3.090

5.  Seroprevalence of Bartonella spp., Coxiella burnetii, and Hantavirus among people who inject drugs in Rio de Janeiro, Brazil: a retrospective assessment of a biobank.

Authors:  Tatiana Rozental; Anamaria Szrajbman Vaz da Silva; Renata Carvalho de Oliveira; Alexsandra Rodrigues de Mendonça Favacho; Maria de Lourdes Aguiar Oliveira; Francisco Inácio Bastos; Elba Regina Sampaio de Lemos
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2018-07-19       Impact factor: 1.846

6.  Congenitally transmitted visceral leishmaniasis: report of two Brazilian human cases.

Authors:  Myrlena Regina Machado Mescouto-Borges; Érika Maués; Dorcas Lamounier Costa; Maria Cristina da Silva Pranchevicius; Gustavo Adolfo Sierra Romero
Journal:  Braz J Infect Dis       Date:  2013-02-27       Impact factor: 3.257

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.